Manager × security

ORBIMED ADVISORS LLC EWTX holdings history

Who else holds this security? →

EDGEWISE THERAPEUTICS INC · CUSIP 28036F105 · CIK 1055951

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, ORBIMED ADVISORS LLC reported 15.52M EWTX (shares), valued at $630.52M, or 12.01% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
12.01%
Shares
15.52M
15,518,492
Reported value
$630.52M
USD

Shares unchanged; reported value increased 28.98%, and weight changed +1.30 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 202612.01%15,518,492SEC filing ↗Filed Aug 14, 2026
Q1 202610.71%15,518,492SEC filing ↗Filed May 15, 2026
Q4 20257.91%15,518,492SEC filing ↗Filed Feb 17, 2026
Q3 20256.05%15,518,492SEC filing ↗Filed Nov 14, 2025
Q2 20255.13%15,518,492SEC filing ↗Filed Aug 14, 2025
Q1 20257.96%15,021,721SEC filing ↗Filed May 15, 2025
Q4 20248.36%15,021,721SEC filing ↗Filed Feb 14, 2025
Q3 20247.37%15,021,721SEC filing ↗Filed Nov 14, 2024
Q2 20245.41%15,021,721SEC filing ↗Filed Aug 14, 2024
Q1 20245.06%15,021,721SEC filing ↗Filed May 15, 2024
Q4 20233.22%14,567,176SEC filing ↗Filed Feb 14, 2024
Q3 20231.81%14,567,176SEC filing ↗Filed Nov 14, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20231.81%14,567,176$83.47MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 14, 2023
Q4 20233.22%14,567,176$159.36MShares unchanged; reported value increased 90.92%, and weight changed +1.41 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2024
Q1 20245.06%15,021,721$274.00MShares increased 3.12%; reported value increased 71.93%, and weight changed +1.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20245.41%15,021,721$270.54MShares unchanged; reported value decreased 1.26%, and weight changed +0.35 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20247.37%15,021,721$400.93MShares unchanged; reported value increased 48.20%, and weight changed +1.96 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20248.36%15,021,721$401.08MShares unchanged; reported value increased 0.04%, and weight changed +0.99 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20257.96%15,021,721$330.48MShares unchanged; reported value decreased 17.60%, and weight changed -0.40 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20255.13%15,518,492$203.45MShares increased 3.31%; reported value decreased 38.44%, and weight changed -2.83 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20256.05%15,518,492$251.71MShares unchanged; reported value increased 23.72%, and weight changed +0.92 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20257.91%15,518,492$385.09MShares unchanged; reported value increased 52.99%, and weight changed +1.86 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 202610.71%15,518,492$488.83MShares unchanged; reported value increased 26.94%, and weight changed +2.80 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 202612.01%15,518,492$630.52MShares unchanged; reported value increased 28.98%, and weight changed +1.30 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
ORBIMED ADVISORS LLC · EDGEWISE THERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1055951","quarter":"2026Q2","cusip":"28036F105"}

get_institutional_manager_history
{"cik":"1055951","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.